Back
Zevra Therapeutics Vs. Xeris Biopharma Holdings Industry Stock Comparison
Buy
67
ZVRA
Zevra Therapeutics
Last Price:
9.63
Seasonality Move:
6.65%
Buy
83
XERS
Xeris Biopharma Holdings
Last Price:
3.09
Seasonality Move:
5.57%
Buy
67
Zevra Therapeutics (ZVRA)
is a Buy
Is Zevra Therapeutics a Buy, Sell or Hold?
- The current Zevra Therapeutics [ZVRA] share price is $9.59. The Score for ZVRA is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
- ZVRA is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
83
Xeris Biopharma Holdings (XERS)
is a Buy
Is Xeris Biopharma Holdings a Buy, Sell or Hold?
- The current Xeris Biopharma Holdings [XERS] share price is $3.09. The Score for XERS is 83, which is 66% above its historic median score of 50, and infers lower risk than normal.
- XERS is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
ZVRA Stock Price Chart
What is Zevra Therapeutics's stock price today?
-
The Zevra Therapeutics share price today is $9.59
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ZVRA is experiencing buying pressure, which is a positive indicator for future bullish movement.
XERS Stock Price Chart
What is Xeris Biopharma Holdings's stock price today?
-
The Xeris Biopharma Holdings share price today is $3.09
The current trend is relatively stagnant and XERS is experiencing buying pressure, which is a positive indicator for future bullish movement.
ZVRA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.29 | Buy |
| Relative Strength Index (14 RSI): | 67.47 | Buy |
| Chaikin Money Flow: | 525632 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (8.17 - 9.01) | Buy |
| Bollinger Bands (100): | (6.44 - 8.48) | Buy |
XERS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.01 | Sell |
| Relative Strength Index (14 RSI): | 49.73 | Sell |
| Chaikin Money Flow: | 551092 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.02 - 3.3) | Sell |
| Bollinger Bands (100): | (2.46 - 3.1) | Buy |
ZVRA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 8.94 | Buy |
| 20-day SMA: | 8.71 | Buy |
| 50-day SMA: | 8.19 | Buy |
| 200-day SMA: | 6.36 | Buy |
| 8-day EMA: | 9.03 | Buy |
| 20-day EMA: | 8.75 | Buy |
| 50-day EMA: | 8.23 | Buy |
| 200-day EMA: | 6.77 | Buy |
XERS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.03 | Buy |
| 20-day SMA: | 3.17 | Sell |
| 50-day SMA: | 3.03 | Buy |
| 200-day SMA: | 2.51 | Buy |
| 8-day EMA: | 3.07 | Buy |
| 20-day EMA: | 3.1 | Sell |
| 50-day EMA: | 3.01 | Buy |
| 200-day EMA: | 2.6 | Buy |
Zevra Therapeutics Earnings Growth & ZVRA Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.33 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.75 per share, and an increase next year of $1.62 per share.
Xeris Biopharma Holdings Earnings Growth & XERS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.13 per share, and an increase next year of $0.06 per share.
Zevra Therapeutics Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Xeris Biopharma Holdings Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||